However, in vitro experiments revealed that exogenous supplementation with miR-145 and miR-143 did not completely reverse the proatherogenic effects induced by CARMN silencing, suggesting that CARMN knockdown may promote atherosclerosis progression through additional mechanisms [17]. The gene discussed is CARMN; the disease is atherosclerosis.